Melatonin inhibits growth of cultured human uveal melanoma cells

Melanoma Research

Volumn 7, Issue 1, 1997, Pages 27-31

  Hu, D N ^a,b   Roberts, J E ^c  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c FORDHAM UNIVERSITY   (United States)

Author keywords

bromodeoxyuridine; melatonin; uveal melanoma

Indexed keywords

BROXURIDINE; MELATONIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UVEA MELANOMA;

BROMODEOXYURIDINE; CELL DIVISION; HUMANS; LIVER NEOPLASMS; MELANOMA; MELATONIN; TUMOR CELLS, CULTURED;

EID: 0031046281     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199702000-00005     Document Type: Article

References (26)

1. Shields PA, Shields CL, Donoso LA. Management of posterior uveal melanoma. Surv Ophthalmol 1991; 36: 161-195.
2. Rajpal S, Moore R, Karakousis CP. Survival in metastatic ocular melanoma. Cancer 1983; 52: 334-336.
3. Cardinali DP, Rosner TM. Retinal localization of hydroxyindole-O-methyltransferase (HIOMT) in the rat. Endocrinology 1971; 86: 301-303.
4. Martin XD, Malina HZ, Brennan MC, et al. The ciliary body - the third organ found to synthesize indoleamines in humans. Eur J Ophthalmol 1992; 2: 67-72.
5. Roberts JE. Visible light induced changes in the immune response through an eye-brain mechanism (photoneuroimmunology). J Photochem Photobiol 1995; 29: 3-15.
6. Morgan PJ, Barrett P, Howell E, et al. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 1994; 24: 101-146.
7. Walhauser F, Steger J, Vorkapic P. Melatonin secretion in man and the influence of exogenous melatonin on some physiological and behavior variables. Adv Pineal Res 1987; 2: 207-223.
8. Aubert C, Janiaud P, Lecalvez J. Effect of pinealectomy and melatonin on mammary tumor growth in Sprague-Dawley rats under different conditions of lighting. J Neural Transm 1980; 47: 121-130.
9. Roselle D, Tamarkin L, Chabner B, et al. Melatonin suppresses and pinealectomy enhances dimethylbenzanthacene breast carcinogenesis in the rat. Clin Res 1980; 28: 522A.
10. Karmali RA, Horrobin DF, Ghayur T. Role of the pineal gland in aetiology and treatment of breast cancer. Lancet 1978; ii: 1002.
11. Das Gupta TK, Terz J. Influence of pineal gland on the growth and spread of melanoma in hamster. Cancer Res 1976; 27: 1306-1311.
12. Narita T, Kudo H. Effect of melatonin on B16 melanoma growth in athymic mice. Cancer Res 1985; 45: 4175-4177.
13. Blask DE, Hill SM. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J Neural Transm 1986; 21: 433.
14. Hill SM, Blask DE. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture Cancer Res 1988; 48: 6121-6126.
15. Shellard SA, Whelan RDH. Hill BT. Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumour cell lines in vitro. Br J Cancer 1989; 60: 288-190.
16. Ying SW, Niles LP, Crocker C. Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin Eur J Pharmacol 1993; 246: 89-96.
17. Slominski A, Pruski D. Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp Cell Res 1993; 206: 189-194.
18. Soulieres D, Rousseau A, Deschenes J, et al. Characterization of gangliosides in human uveal melanoma cells. Int J Cancer 1991; 49: 498-503.
19. Meyskens FL, Salmon SE. Modulation of clonogenic human melanoma cells by follicle-stimulating hormone, melatonin and nerve growth factor. Br J Cancer 1981; 43: 111-115.
20. Jovanovic SV, Simic MG. One-electron reduction potentials of 5-indoxyl radicals: a pulse radiolysis and laser photolysis study. J Phys Chem 1989; 94: 3583-3588.
21. Helton RA. Harrison WA, Kelley K, et al. Melatonin interactions with cultured murine B16 melanoma cells. Melanoma Res 1993; 3: 403-413.
22. Bartsch C, Bartsch H, Fuchs U, et al. Stage-dependent depression of melatonin in patients with breast cancer. Cancer 1989; 64: 426-433.
23. Lissoni P, Barni S, Cattaneo G, et al. Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies. Oncology 1991; 48: 448-450.
24. McClay EF, Mastrangelo MJ, Beerd D, et al. Effective combination chem/hormonal therapy for malignant melanoma: experience with three consecutive trials. Int J Cancer 1992; 50: 53-556.
25. Lissoni P, Barni S, Ardizzoia A. et al. Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatin. Oncology 1992; 49: 336-339.
26. Gonzalez R, Sanchez A, Ferguson JA, et al Melatonin therapy of advanced human malignant melanoma. Melanoma Res 1991; 1: 237-243.